Increased Fracture Risk in Patients with Untreated Chronic Lymphocytic Leukemia (CLL): A Population-Based Analysis

被引：0
|
作者：
Olszewski, Adam J. [1 ]
Gutman, Roee [2 ]
Eaton, Charles B. [3 ]
机构：
[1] Brown Univ, Alpert Med Sch, Div Hematol Oncol, Providence, RI 02912 USA
[2] Brown Univ, Dept Biostat, Providence, RI 02912 USA
[3] Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI 02912 USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Infection Risk Evaluation Based on a Novel Scoring System in Chronic Lymphocytic Leukemia (CLL) Patients at Diagnosis
    Murru, Roberta
    Galitzia, Andrea
    Caocci, Giovanni
    Barabino, Luca
    Presicci, Roberta
    Culurgioni, Fabio
    Massidda, Stefania
    Oppi, Sara
    La Nasa, Giorgio
    BLOOD, 2022, 140 : 4144 - 4145
  • [32] INCREASED SUSCEPTIBILITY OF CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) LYMPHOCYTES TO ADENOSINE
    BAJAJ, S
    INSEL, J
    QUAGLIATA, F
    HIRSCHHORN, R
    SILBER, R
    CLINICAL RESEARCH, 1977, 25 (03): : A405 - A405
  • [33] Cardiovascular Risk Associated With Ibrutinib Use in Chronic Lymphocytic Leukemia: A Population-Based Cohort Study
    Abdel-Qadir, Husam
    Sabrie, Nasruddin
    Leong, Darryl
    Pang, Andrea
    Austin, Peter C.
    Prica, Anca
    Nanthakumar, Kumaraswamy
    Calvillo-Arguelles, Oscar
    Lee, Douglas S.
    Thavendiranathan, Paaladinesh
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (31) : 3453 - +
  • [34] Use of antibiotics and risk of chronic lymphocytic leukemia: a population-based case-control study
    Andersen, Michael Asger
    Rostgaard, Klaus
    Niemann, Carsten Utoft
    Hjalgrim, Henrik
    LEUKEMIA & LYMPHOMA, 2020, 61 : 84 - 86
  • [35] 2-CHLORODEOXYADENOSINE (CDA) FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
    DELANNOY, A
    MARTIAT, P
    BOSLY, A
    FERRANT, A
    DENEYS, V
    MICHAUX, JL
    BLOOD, 1994, 84 (10) : A461 - A461
  • [36] Prevalence, screening, treatment, and complications of osteoporosis and osteopenia in Medicare patients with chronic lymphocytic leukemia (CLL).lepatients with chronic lymphocytic leukemia (CLL).
    Brander, Danielle M.
    Oeffinger, Kevin C.
    Greiner, Melissa A.
    Dinan, Michaela Ann
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] Alterations of Gut Microbiome in Untreated Chronic Lymphocytic Leukemia (CLL); Future Therapeutic Potentials
    Kawari, Mohammed
    Akhtar, Mahmood
    Sager, Mohamed
    Basbous, Zakaria
    Baydoun, Ibrahim
    Kabanja, Juma
    Darweesh, Mohammed
    Mokhtar, Nihad
    Kanfar, Solaf
    Mutahar, Enas
    Apostolidis, John
    Al-Anazi, Khalid Ahmed
    Al Hashmi, Hani
    BLOOD, 2019, 134
  • [38] A phase II study of lenalidomide in previously untreated, symptomatic chronic lymphocytic leukemia (CLL)
    Chen, Christine I.
    Paul, Harminder
    Mariela, Pantoja
    Brandwein, Joseph
    Kukreti, Vishal
    Trudel, Suzanne
    Wei, Ellen
    Tong, Jieffei
    Moran, Mike
    BLOOD, 2007, 110 (11) : 608A - 608A
  • [39] Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019
    Lina van der Straten
    Mark-David Levin
    Manette A. W. Dinnessen
    Otto Visser
    Eduardus F. M. Posthuma
    Jeanette K. Doorduijn
    Anton W. Langerak
    Arnon P. Kater
    Avinash G. Dinmohamed
    Blood Cancer Journal, 13
  • [40] A Phase II Stud of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)
    Chen, Christine
    Paul, Harminder
    Xu, Wei
    Kukreti, Vishal
    Trudel, Suzanne
    Wei, Ellen
    Li, Zhi Hua
    Brandwein, Joseph
    Pantoja, Mariela
    Leung-Hagensteijn, Chungyee
    BLOOD, 2008, 112 (11) : 23 - 23
12345